Literature DB >> 11336185

The effects of allicin and enalapril in fructose-induced hyperinsulinemic hyperlipidemic hypertensive rats.

A Elkayam1, D Mirelman, E Peleg, M Wilchek, T Miron, A Rabinkov, S Sadetzki, T Rosenthal.   

Abstract

The effects of a synthetic preparation of an active constituent of garlic, allicin, were studied on blood pressure (BP), triglycerides, and insulin levels in Sprague-Dawley rats in which high fructose feeding elicited hyperinsulinemia, hypertension, and hypertriglyceridemia. Results were compared with those of the antihypertensive drug enalapril. Three groups of male Sprague-Dawley rats were fed a fructose-enriched diet for 5 weeks. During the last 2 weeks 10 animals received only fructose, 10 received allicin, and 10 received enalapril. Blood pressure, insulin level, and triglyceride levels were measured at the beginning of the experiment and after 3 and 5 weeks on the fructose diet, fructose/allicin diet, or fructose/enalapril diet. Allicin lowered BP from the maximal level (after 3 weeks of fructose) of 153.4 +/- 8 mm Hg to 139.7 +/- 12 mm Hg after 2 weeks on allicin; insulin from 11.7 +/- 3.7 ng/mL on fructose diet to 6.92 +/- 3.3 ng/mL on allicin; and triglycerides from 132.8 +/- 18 mg/dL on fructose to 59.6 +/- 27 mg/dL on allicin. The similar effect of allicin and enalapril on BP, insulin, and triglycerides reinforces the trend toward combining the nonpharmacologic approach with drug therapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11336185     DOI: 10.1016/s0895-7061(00)01298-x

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  15 in total

1.  Therapeutic actions of allylmercaptocaptopril and captopril in a rat model of metabolic syndrome.

Authors:  Paul Ernsberger; Janean L Johnson; Talma Rosenthal; David Mirelman; Richard J Koletsky
Journal:  Am J Hypertens       Date:  2007-08       Impact factor: 2.689

Review 2.  Nutritional Supplements for the Treatment of Hypertension: A Practical Guide for Clinicians.

Authors:  Jeffrey M Turner; Erica S Spatz
Journal:  Curr Cardiol Rep       Date:  2016-12       Impact factor: 2.931

3.  Allicin inhibits tubular epithelial-myofibroblast transdifferentiation under high glucose conditions in vitro.

Authors:  Hong Huang; Fenping Zheng; Xuehong Dong; Fang Wu; Tianfeng Wu; Hong Li
Journal:  Exp Ther Med       Date:  2016-11-18       Impact factor: 2.447

Review 4.  Mecanismos moleculares de los efectos benéficos de la alicina sobre la enfermedad cardiovascular.

Authors:  Abraham S Arellano-Buendía; Juan G Juárez-Rojas; Fernando E García-Arroyo; Laura G Sánchez-Lozada; Horacio Osorio-Alonso
Journal:  Arch Cardiol Mex       Date:  2022

5.  Allicin inhibits SDF-1alpha-induced T cell interactions with fibronectin and endothelial cells by down-regulating cytoskeleton rearrangement, Pyk-2 phosphorylation and VLA-4 expression.

Authors:  Uri Sela; Sharon Ganor; Iris Hecht; Alexander Brill; Talia Miron; Aharon Rabinkov; Meir Wilchek; David Mirelman; Ofer Lider; Rami Hershkoviz
Journal:  Immunology       Date:  2004-04       Impact factor: 7.397

6.  S-allyl-mercapto-captopril: a novel compound in the treatment of Cohen-Rosenthal diabetic hypertensive rats.

Authors:  Firas Younis; David Mirelman; Aharon Rabinkov; Talma Rosenthal
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-06       Impact factor: 3.738

7.  Effects of Allicin on Hypertension and Cardiac Function in Chronic Kidney Disease.

Authors:  Ehécatl M A García-Trejo; Abraham S Arellano-Buendía; Raúl Argüello-García; María L Loredo-Mendoza; Fernando E García-Arroyo; Mónica G Arellano-Mendoza; María C Castillo-Hernández; Gustavo Guevara-Balcázar; Edilia Tapia; Laura G Sánchez-Lozada; Horacio Osorio-Alonso
Journal:  Oxid Med Cell Longev       Date:  2016-11-21       Impact factor: 6.543

8.  The Beneficial Effects of Allicin in Chronic Kidney Disease Are Comparable to Losartan.

Authors:  Ehécatl Miguel Ángel García Trejo; Abraham Said Arellano Buendía; Omegar Sánchez Reyes; Fernando Enrique García Arroyo; Raúl Arguello García; María Lilia Loredo Mendoza; Edilia Tapia; Laura Gabriela Sánchez Lozada; Horacio Osorio Alonso
Journal:  Int J Mol Sci       Date:  2017-09-16       Impact factor: 5.923

9.  Effect of garlic on cardiovascular disorders: a review.

Authors:  Sanjay K Banerjee; Subir K Maulik
Journal:  Nutr J       Date:  2002-11-19       Impact factor: 3.271

Review 10.  Therapeutic uses and pharmacological properties of garlic, shallot, and their biologically active compounds.

Authors:  Peyman Mikaili; Surush Maadirad; Milad Moloudizargari; Shahin Aghajanshakeri; Shadi Sarahroodi
Journal:  Iran J Basic Med Sci       Date:  2013-10       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.